Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1 Stroke 1 Skin Neoplasms 1 Sarcoma 1 Restless Legs Syndrome 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Odontogenic Cysts 1 Multiple Sclerosis 1 Migraine Disorders 1 Localized Advanced Rectal Adenocarcinoma 1 Keratosis, Actinic 1 Inflammatory Bowel Diseases 1 Hematoma 1 Esophageal Neoplasms 1 Epilepsy 1 Dysbiosis 1 Crohn Disease 1 Colitis, Ulcerative 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Brain Concussion 1 Bone Neoplasms 1

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Enrolling by invitation × Dysbiosis × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡